SillaJen Inc
SillaJen, Inc. engages in developing technologies and products using genetic engineering in South Korea. The company develops Pexa-Vec, which is in phase 2 clinical trial to treat renal Cell Carcinoma and prostate cancer, as well as in phase 1 clinical trial to treat melanoma and solid tumors. It also develops BAL0891, which is in phase 1 clinical trial for the treatment of solid tumors; and SJ-6… Read more
SillaJen Inc (215600) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.040x
Based on the latest financial reports, SillaJen Inc (215600) has a cash flow conversion efficiency ratio of -0.040x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.74 Billion) by net assets (₩117.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SillaJen Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how SillaJen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
SillaJen Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SillaJen Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
M. Dias Branco S.A. Indústria e Comércio de Alimentos
SA:MDIA3
|
0.064x |
|
Scimee Sci &Tech Co Ltd
SHE:300425
|
0.039x |
|
Beijing ConST Instruments Technology Inc
SHE:300445
|
0.040x |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
0.003x |
|
Anhui Gourgen Traffic Construction Co Ltd
SHG:603815
|
-0.050x |
|
HALSTEAD JAMES LS-05
F:HSJA
|
N/A |
|
Fujian SuperTech Advanced Material Co Ltd
SHG:688398
|
0.016x |
|
Eventbrite Inc Class A
NYSE:EB
|
0.194x |
Annual Cash Flow Conversion Efficiency for SillaJen Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of SillaJen Inc from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩131.82 Billion | ₩-17.83 Billion | -0.135x | +54.44% |
| 2023-12-31 | ₩57.31 Billion | ₩-17.02 Billion | -0.297x | -5.86% |
| 2022-12-31 | ₩78.94 Billion | ₩-22.14 Billion | -0.280x | +50.07% |
| 2021-12-31 | ₩108.05 Billion | ₩-60.69 Billion | -0.562x | +43.98% |
| 2020-12-31 | ₩22.88 Billion | ₩-22.94 Billion | -1.003x | -241.83% |
| 2018-12-31 | ₩165.09 Billion | ₩-48.43 Billion | -0.293x | -275.11% |
| 2017-12-31 | ₩201.95 Billion | ₩33.83 Billion | 0.168x | +117.60% |
| 2016-12-31 | ₩207.97 Billion | ₩-197.98 Billion | -0.952x | -269.66% |
| 2015-12-31 | ₩86.94 Billion | ₩-22.39 Billion | -0.258x | -- |